MwanzoDMYD-B • STO
add
Diamyd Medical AB
Bei iliyotangulia
kr 8.30
Bei za siku
kr 8.38 - kr 9.50
Bei za mwaka
kr 7.50 - kr 25.00
Thamani ya kampuni katika soko
1.16B SEK
Wastani wa hisa zilizouzwa
elfu 298.44
Uwiano wa bei na mapato
-
Mgao wa faida
-
Ubadilishanaji wa msingi
STO
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (SEK) | Feb 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | elfu 86.00 | 230.77% |
Matumizi ya uendeshaji wa biashara | 44.69M | 59.86% |
Mapato halisi | -44.87M | -53.39% |
Kiwango cha faida halisi | elfu -52.17 | 53.63% |
Mapato kwa kila hisa | — | — |
EBITDA | -44.01M | -60.78% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (SEK) | Feb 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 103.75M | -24.35% |
Jumla ya mali | 180.88M | -20.13% |
Jumla ya dhima | 69.35M | 53.23% |
Jumla ya hisa | 111.53M | — |
hisa zilizosalia | 104.09M | — |
Uwiano wa bei na thamani | 7.76 | — |
Faida inayotokana na mali | -56.58% | — |
Faida inayotokana mtaji | -85.35% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (SEK) | Feb 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | -44.87M | -53.39% |
Pesa kutokana na shughuli | -48.41M | -36.64% |
Pesa kutokana na uwekezaji | elfu -458.00 | 86.82% |
Pesa kutokana na ufadhili | elfu -635.00 | -203.83% |
Mabadiliko halisi ya pesa taslimu | -49.13M | -24.15% |
Mtiririko huru wa pesa | -32.72M | -9.70% |
Kuhusu
Diamyd Medical AB is a small biotechnology company headquartered in Stockholm, Sweden that focuses on immune modifying therapies for diabetes. The company is developing two products.
The company is headquartered in Stockholm, and maintains a manufacturing facility in Umeå. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1984
Tovuti
Wafanyakazi
30
